Anvisa aprova primeiro medicamento de GLP-1 oral para obesidade

Imported from official source

Announcement

Safety Classified by Officially

Produto é indicado para tratamento de perda e manutenção do peso em adultos

Read the original at the source: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2026/anvisa-aprova-primeiro-medicamento-de-glp-1-oral-para-obesidade

Officially imported this from Agência Nacional de Vigilância Sanitária (Anvisa)’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

This publication has changed since it was first published

2 versions recorded. The original is kept in full — nothing is overwritten.

  1. v2 imported change on current
  2. v1 as first published on

Provenance

Organization
Agência Nacional de Vigilância Sanitária (Anvisa) — imported from official source
Official source
https://www.gov.br/anvisa/++api++/@search?portal_type=News%20Item&sort_on=effective&sort_order=reverse&b_size=25&metadata_fields=effective&metadata_fields=UID API
Imported
November 04, 2026 09:01
Versions
2 recorded
Identity
13f774ce8dd5492f8416c49b35cb549f

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.